comprehensive -WSS

comprehensive

author：comprehensive 2025-09-27 23:02:16 - browse：2757

Photo illustration of Chris Viehbacher -- biotech coverage from STAT — Chris Viehbacher took over as Biogen CEO in November. Suzanne Kreiter/Globe staff; Photo illustration Alex Hogan/STAT

This was supposed to be the new Biogen. When Chris Viehbacher, a respected pharmaceutical executive, took over as CEO in November, Wall Street saw him as a steadying force for the wayward company and a strong personality who would stand up to its quarrelsome board.

Instead, Biogen’s board has saddled Viehbacher with the first crisis of his tenure at the company. Alex Denner, a long-time director, nominated a biotech executive who is also the mother of his child to succeed him on the board, and Biogen chose not to disclose the couple’s relationship to shareholders, an omission that shocked people close to the company and undermined the notion that Biogen was changing for the better.

“It’s just disappointing to see after all the criticism that has been levied at the company over the last few years, there really seems to be no self-awareness going into this recommendation,” said Brian Skorney, a securities analyst at Baird who covers Biogen.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： An interview with Robert F. Kennedy Jr. on vaccines

focus

entertainment

WSS

New definition of a human embryo proposed amid rapid advances

After sickle

ProMED sees offers of support, but its future remains unclear

What PEPFAR has meant on the ground in Ukraine

Spinal cord stimulation reduces pain in amputees, study finds

Pregnancy discrimination could be enabled by AI

entertainment

comprehensive

explore

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Patient advocates sound warning on FDA proposal on salt intake

Jerome Adams on the need for new antivirals for Covid

Supreme Court wrestles with OxyContin maker's bankruptcy deal

Hepatitis C has a cure — but many Americans still lack access to it

Lung cancer is America's deadliest cancer. Yet so few get screened

Bright Health sells Medicare Advantage business to Molina

An interview with Robert F. Kennedy Jr. on vaccines

Medical records are filled with copy

Beware the threat of staffing cuts at the CDC

knowledge

Supreme Court wrestles with OxyContin maker's bankruptcy deal

The pain doctors face in trying to build their families

After sickle

Evacuations in place as 3 wildfires burn in eastern Washington state

After sickle

Special counsel raises new conflict of interest concerns for De Oliveira's lawyer

focus

entertainment

hotspot

knowledge